Intellia Therapeutics, Inc. (NTLA)

14.55 +0.52 (+3.71%) USD  |  NASDAQ  |  Jan 22, 10:11
More

Intellia Therapeutics Extraordinary Items, Income Statement (Quarterly)

Extraordinary Items, Income Statement (Quarterly) Chart

View Extraordinary Items, Income Statement (Quarterly) for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Extraordinary Items, Income Statement (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Extraordinary Items, Income Statement (Quarterly) Range, Past 5 Years

View Extraordinary Items, Income Statement (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Extraordinary Items, Income Statement (Quarterly) Benchmarks

View Extraordinary Items, Income Statement (Quarterly) Benchmarks
Start Trial
Beam Therapeutics, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Pacific Biosciences of California, Inc. Upgrade
Twist Bioscience Corp. Upgrade